26 results
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
15 Aug 24
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
8:40am
impacted by COVID-related disruptions affecting the Company’s manufacturing operations and production and raw materials used in the research
6-K
EX-99.1
tx560
19 Apr 24
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
8:03am
POS AM
iv540 e3sd9a
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
424B3
1yo6eucm49 ju1xxb
15 Aug 23
Prospectus supplement
8:00am
POS AM
nsgf1dga190uw1k
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
20-F
i5ew86x 1k80hz
26 Jul 23
Annual report (foreign)
4:02pm
424B3
jdb tsi30
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
xt702cm9hneoh6mp
12 May 23
Registration statement (foreign) (amended)
4:05pm
F-1
5uxre
12 Apr 23
Registration statement (foreign)
8:49am
F-1
EX-23.3
5mpm29dg d9rppsy
12 Apr 23
Registration statement (foreign)
8:49am
F-4
EX-3.2
2q5oehh7ef
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-99.2
s5vp95gdcr dpns892gd
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-10.10
yma4ybd135mmgqz43
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-23.3
n05e8bqi
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
j4davzru4 ht16jsir
28 Dec 22
Registration of securities (foreign)
6:58am
DRS/A
3zd 7nvvdf
7 Dec 22
Draft registration statement (amended)
12:00am